捆绑SM社区

Gears with various health icons within them

We create synergies

Continuously in the pursuit of developing new partnerships with leading national and international connections, while deepening the existing ones.

News

Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19 - MUHC press release - September 2, 2020

Published: 2 October 2020

Dr. Jean Bourbeau (Department of Epidemiology, Biostatistics and Occcupational Health Associate member) is the principal investigator on a clinical trial on a reformulated generic drug in COVID-19 positive outpatients.

See also:

- (article in French) La Presse, September 3, 2020

- (article in French) Journal de Montr茅al, September 3, 2020

Back to top